Phase 3 Clinical Trials
166 trials are at Phase 3 in the index.
Trials (166)
- Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Phase 3 · German CLL Study Group
- Optimisation of Follicular Recruitment in IVM Cycles Phase 3 · Universitair Ziekenhuis Brussel
- A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia Phase 3 · Ariad Pharmaceuticals
- A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma Phase 3 · The Lymphoma Academic Research Organisation
- PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC Phase 3 · Sun Yat-sen University
- Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years Phase 3 · University Hospital, Toulouse
- Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma Phase 3 · SecuraBio
- Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia. Phase 3 · Trans Tasman Radiation Oncology Group
- A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer Phase 3 · Betta Pharmaceuticals Co., Ltd.
- Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer Phase 3 · GERCOR - Multidisciplinary Oncology Cooperative Group
- A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC Phase 3 · Sun Yat-sen University
- Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer Phase 3 · Alliance for Clinical Trials in Oncology
- A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials Phase 3 · Celgene
- Evaluate the Efficacy and Safety of HLX01 Versus Mabthera in Patients With Low Tumour Burden Follicular Lymphoma. Phase 3 · Shanghai Henlius Biotech
- A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT) Phase 3 · Spectrum Pharmaceuticals, Inc
- A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer Phase 3 · Pfizer
- JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects Phase 3 · Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer Phase 3 · Ukrainian Society of Clinical Oncology
- HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. Phase 3 · National Cancer Institute, Naples
- Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer Phase 3 · Medical Research Council
- Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma Phase 3 · Grupo de Estudos Multicentricos em Onco-Hematologia
- Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk Phase 3 · Ohio State University Comprehensive Cancer Center
- Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC) Phase 3 · Singapore General Hospital
- UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma Phase 3 · University of Arkansas
- Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer Phase 3 · National Cancer Institute (NCI)
- A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma). Phase 3 · Genzyme, a Sanofi Company
- Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut Phase 3 · Carmen Schade-Brittinger
- Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study) Phase 3 · AbbVie
- A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant Phase 3 · Sinocelltech Ltd.
- A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer Phase 3 · UroGen Pharma Ltd.
- To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) Phase 3 · Incyte Corporation
- Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence. Phase 3 · Centre Oscar Lambret
- Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions Phase 3 · AIDS Malignancy Consortium
- Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Phase 3 · Jonsson Comprehensive Cancer Center
- Vebreltinib Plus PLB1004 Versus Platinum-based Doublet Chemotherapy in Patients With EGFRm, MET+, Locally Advanced or Metastatic NSCLC Following EGFR-TKI Failure Phase 3 · Avistone Biotechnology Co., Ltd.
- Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia Phase 3 · Children's Oncology Group
- Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients Phase 3 · Fudan University
- Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC) Phase 3 · Sumitomo Pharma Co., Ltd.
- Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) Phase 3 · Xiamen University
- (VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST Phase 3 · Blueprint Medicines Corporation
- HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC Phase 3 · Sun Yat-sen University
- Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 Phase 3 · GlaxoSmithKline
- Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer Phase 3 · Sanofi
- Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation Phase 3 · Novartis Pharmaceuticals
- Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis Phase 3 · Encube Ethicals Pvt. Ltd.
- A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment Phase 3 · Geron Corporation
- IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer Phase 3 · Hokkaido Gastrointestinal Cancer Study Group
- A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor Phase 3 · GlaxoSmithKline
- Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma Phase 3 · NX Development Corp
- Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence Phase 3 · Jagiellonian University
Related landscapes
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.